These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32054979)

  • 1. A decade of extreme oscillations in opioid control and availability: implications for public health in a Canadian setting.
    Fischer B; Wood E
    J Public Health Policy; 2020 Jun; 41(2):214-220. PubMed ID: 32054979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.
    Fischer B; Jones W; Tyndall M; Kurdyak P
    BMC Public Health; 2020 Jan; 20(1):143. PubMed ID: 32005211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010.
    Murphy Y; Goldner EM; Fischer B
    Pain Physician; 2015; 18(4):E605-14. PubMed ID: 26218951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Fischer B; Pang M; Jones W
    Subst Abuse Treat Prev Policy; 2020 Feb; 15(1):14. PubMed ID: 32066470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
    Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
    Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid dispensing in Canada: an update on recent developments to 2018.
    Jones W; Vojtila L; Kurdyak P; Fischer B
    J Pharm Policy Pract; 2020; 13():68. PubMed ID: 33110608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.
    Fischer B; Gooch J; Goldman B; Kurdyak P; Rehm J
    Can J Public Health; 2014 Apr; 105(2):e146-9. PubMed ID: 24886852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why comparative epidemiological indicators suggest that New Zealand is unlikely to experience a severe opioid epidemic.
    Fischer B; O-Keefe-Markman C; Daldegan-Bueno D; Walters C
    Int J Drug Policy; 2021 Jul; 93():103166. PubMed ID: 33607479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
    Zheng D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):521-527. PubMed ID: 30790376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010.
    Fischer B; Jones W; Krahn M; Rehm J
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1269-77. PubMed ID: 21755568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
    Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and sex differences in prescription opioid deaths in British Columbia, Canada.
    Gladstone EJ; Smolina K; Morgan SG
    Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later.
    Fischer B; Rehm J
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S199-S202. PubMed ID: 28334467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.
    Jones W; Kurdyak P; Fischer B
    BMC Health Serv Res; 2020 Jul; 20(1):677. PubMed ID: 32698815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'fentanyl epidemic' in Canada - Some cautionary observations focusing on opioid-related mortality.
    Fischer B; Vojtila L; Rehm J
    Prev Med; 2018 Feb; 107():109-113. PubMed ID: 29126920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall.
    Jones W; Kaoser R; Fischer B
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):65. PubMed ID: 34521418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.
    Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J
    Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wanted: a public health approach to prescription opioid abuse and diversion.
    Joranson DE; Gilson AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.